5 - fluorouracil ebewe 50mg/ml
ebewe pharma ges.m.b.h. nfg. kg - austria - fluorouracilum - conc. pt. sol. inj./perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
5-fluorouracil "ebewe" concentrat pentru solutie perfuzabila 250 mg/5 ml
ebewe pharma gmbh nfg. kg - concentrat pentru solutie perfuzabila - 250 mg/5 ml
5-fluorouracil "ebewe" concentrat pentru solutie perfuzabila 500 mg/10 ml
ebewe pharma gmbh nfg. kg - concentrat pentru solutie perfuzabila - 500 mg/10 ml
fluorouracil accord 50 mg/ml
accord healthcare limited - marea britanie - fluorouracilum - sol. inj. sau perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
fluorouracil accord 50 mg/ml
accord healthcare polska sp. z.o.o. - polonia - fluorouracilum - sol. inj. sau perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
fluorouracil accord 50 mg/ml
accord healthcare limited - marea britanie - fluorouracilum - sol. inj. sau perf. - 50mg/ml - antimetaboliti analogi ai bazelor pirimidinice
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - imunostimulante, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
topotecan ebewe 1 mg/ml
ebewe pharma ges.m.b.h. nfg. kg - austria - topotecamum - conc. pt. sol. perf. - 1mg/ml - alte antineoplazice alte antineoplazice
oxaliplatin ebewe 5mg/ml
ebewe pharma ges.m.b.h nfg. kg - austria - oxaliplatinum - conc. pt. sol. perf. - 5 mg/ml - alte antineoplazice compusi de platina
gemsol 40 mg/ml
ebewe pharma ges.m.b.h nfg. kg - austria - gemcitabinum - conc. pt. sol. perf. - 40mg/ml - antimetaboliti analogi ai bazelor pirimidinice